Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Biological activity of ZD-7944 characterized in vitro and in animals

Dec. 10, 1998

Merck & Co. revises safety information on Singulair for U.S. healthcare professionals

Dec. 9, 1998

Magainin scientists identify new therapeutic target for asthma: interleukin-9

Dec. 9, 1998

Novel compounds from P&G behave as alpha2-adrenoceptor agonists

Dec. 7, 1998

First results from infant trial indicate utility of cetirizine for preventing development of asthma

Dec. 4, 1998

Comparison of LT and TxA2 antagonists in asthmatic patients

Dec. 2, 1998

Albuterol delivered by novel MSI system enters clinical evaluation

Dec. 2, 1998

Asthma program accelerated by Genome Therapeutics and Schering-Plough

Dec. 1, 1998

PDE4 inhibitor developed at Celltech superior to available antiasthmatic agents in rabbit model

Nov. 27, 1998

Montelukast shows synergistic efficacy with antihistamines in allergic rhinitis

Nov. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...